Cargando…
Efficacy of trabectedin in advanced soft tissue sarcoma: beyond lipo- and leiomyosarcoma
OBJECTIVE: Trabectedin is effective in leiomyosarcoma and liposarcoma, especially the myxoid variant, related to the presence of the FUS-CHOP transcript. We evaluated the efficacy of trabectedin in specific subgroups of patients with soft tissue sarcomas (STS). METHODS: Seventy-two patients with adv...
Autores principales: | De Sanctis, Rita, Marrari, Andrea, Marchetti, Silvia, Mussi, Chiara, Balzarini, Luca, Lutman, Fabio Romano, Daolio, Primo, Bastoni, Stefano, Bertuzzi, Alexia Francesca, Quagliuolo, Vittorio, Santoro, Armando |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4629957/ https://www.ncbi.nlm.nih.gov/pubmed/26604682 http://dx.doi.org/10.2147/DDDT.S92395 |
Ejemplares similares
-
Efficacy of trabectedin in advanced soft tissue sarcoma: beyond lipo- and leiomyosarcoma [Corrigendum]
Publicado: (2016) -
Activity of regorafenib in advanced pretreated soft tissue sarcoma: Results of a single-center phase II study
por: Marrari, Andrea, et al.
Publicado: (2020) -
Multidisciplinary management of adolescents and young adults (AYA) sarcoma: A successful effort of an adult high‐volume cancer center
por: Bertuzzi, Alexia Francesca, et al.
Publicado: (2023) -
Low Incidence of SARS-CoV-2 in Patients with Solid Tumours on Active Treatment: An Observational Study at a Tertiary Cancer Centre in Lombardy, Italy
por: Bertuzzi, Alexia Francesca, et al.
Publicado: (2020) -
The radiologist empowerment through virtual multidisciplinary tumor boards: The commitment of oncologic care during COVID-19 pandemic
por: Gennaro, Nicolò, et al.
Publicado: (2021)